14 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Opinion status
Positive Remove Positive filter
-
List item
Summary of opinion: Taltz
ixekizumab, opinion date: 28/05/2020, Positive, Last updated: 29/05/2020 -
List item
Summary of opinion: Alunbrig
brigatinib, opinion date: 27/02/2020, Positive, Last updated: 28/02/2020 -
List item
Summary of opinion: Sovaldi
sofosbuvir, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Carmustine Obvius
carmustine, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Fingolimod Accord
fingolimod, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Taltz
ixekizumab, opinion date: 28/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Braftovi
encorafenib, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Apixaban Accord
apixaban, opinion date: 28/05/2020, Positive, Last updated: 29/05/2020 -
List item
Summary of opinion: Harvoni
ledispavir / sofosbuvir, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Ervebo
Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live), opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Ultomiris
ravulizumab, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Darzalex
daratumumab, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Cablivi
caplacizumab, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Adcetris
brentuximab vedotin, opinion date: 26/03/2020, Positive, Last updated: 27/03/2020